Based on the above literature, it is reasonable to speculate that the use of anti-inflammatory drugs can cooperate with PD-1/PD-L1 inhibitors to suppress the tumor immune escape and synergistically enhance the therapeutic effect of PD-1/PD-L1 inhibitors. The gene discussed is PDCD1; the disease is neoplasm.